FDA Expands Nicotine Pouch Approvals And Grants ZYN Reduced-Risk Claim
The Food and Drug Administration authorized marketing of four new flavored nicotine pouches from the on! brand on Tuesday, August 4, 2026, expanding federal approvals for the product category and prompting public-health concerns.[1]
The move brings the total number of nicotine pouch products the FDA has cleared to 30.[1] In June 2026 the agency separately approved 20 ZYN products as modified-risk tobacco products, allowing claims that using ZYN instead of cigarettes lowers the risk of several major diseases.[1]
Between January 2023 and August 2025 U.S. nicotine pouch sales rose about 250%, making them the fastest-growing tobacco segment. Roughly 460,000 U.S. middle and high school students reported using nicotine pouches in the latest National Youth Tobacco Survey.
Some doctors warned that broad marketing approvals could normalize nicotine use and increase youth uptake, undermining tobacco-control gains.[1] The approvals are likely to sharpen the debate between harm-reduction advocates and those who prioritize blocking youth access as regulators consider future product reviews.
Show source details & analysis (1 source)
📌 Key Facts
- On Tuesday, August 4, 2026, the FDA authorized marketing of four new flavored nicotine pouches from the 'on!' brand.
- The FDA has now recently greenlit marketing for 30 nicotine pouch products in total.
- In June 2026, the FDA approved 20 ZYN products as modified-risk tobacco products, allowing claims that using ZYN instead of cigarettes lowers risk of several major diseases.
- Between January 2023 and August 2025, U.S. nicotine pouch sales rose about 250%, making them the fastest-growing tobacco segment.
- Roughly 460,000 U.S. middle and high school students reported using nicotine pouches in the latest National Youth Tobacco Survey.
📰 Source Timeline (1)
Follow how coverage of this story developed over time